Harrow (HROW) Acquisitions (2014 - 2015)
Harrow (HROW) recorded quarterly Acquisitions of $3.0 million in Q1 2015, up 605.04% quarter-over-quarter from -$595000.0 in Q2 2014, and up 7429.27% on a YoY basis from $39910.9 in Q1 2014.
Harrow (HROW) Acquisitions (2014 - 2015) Analysis & Trends
Harrow's Acquisitions history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2015.
- In Q1 2015, Acquisitions rose 7429.27% year-over-year to $3.0 million; the TTM figure through Dec 2015 stood at $3.0 million (up 572.48% YoY), while the FY2025 annual figure was $4.4 million, changed N/A from the prior year.
- Acquisitions was $3.0 million for Q1 2015 at Harrow, up from -$595000.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $3.0 million in Q1 2015 to a low of -$595000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 137.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 3.01 Mn |
| Jun 30, 2014 | -595,000.00 |
| Mar 31, 2014 | -41,000.00 |